Form D · Biotechnology
ORTHO REGENERATIVE TECHNOLOGIES INC.
Kirkland, A8 · CIK 0001723032
Offering snapshot reported Oct 15, 2020 · SEC filing
- Reported sold
- $73.4K Offering amount: $73.4K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 1, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 15, 2020 | Initial | $73,394 | No comparison | 2 | SEC filing |
| Nov 27, 2017 | Initial | $50,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $3.4K
- Form D file number
- 021-377925
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Haywood Securities | 42072 |
Source: Form D, filed Oct 15, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Guy Paul Allard | Executive |
| Michael Atkin | Director |
| Michael Buschmann | Director |
| Le Duc Claude | Director, Executive |
| Caroline Hoemann | Director |
| Pierre Laurin | Director |
| Jo Anne Mainguy Piche | Executive |
| Luc Mainville | Executive |
| Brent Norton | Director |
| Laurence Rulleau | Director |
| Steve Saviuk | Director |
| Tom Es Wright | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
16667 Boul Hymus
Kirkland, A8, H9H 4R9
Kirkland, A8, H9H 4R9